Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection

Background. Hepatitis C is a leading cause of mortality among HIV-infected individuals. Therefore, eradication of HCV in this population is a priority. There are scarce data regarding retreatment efficacy of HIV/ HCV coinfected patients. The aim of our study was to evaluate efficacy, predictors of r...

Full description

Bibliographic Details
Main Authors: Mario Peribañez-Gonzalez, Mariliza Henrique daSilva, Fernando Crivelenti Vilar, Ana Catharina Seixas-Santos Nastri, Paulo Abrão Ferreira, Roberto Focaccia, Maria Cássia Mendes Correa
Format: Article
Language:English
Published: Elsevier 2013-03-01
Series:Annals of Hepatology
Subjects:
Non-responders
HIV-HCV coinfected
AIDS
Efficacy
Treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119313614

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119313614

Similar Items